These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1062 related articles for article (PubMed ID: 32786331)
1. Nanomedicines for Renal Management: From Imaging to Treatment. Jiang D; Rosenkrans ZT; Ni D; Lin J; Huang P; Cai W Acc Chem Res; 2020 Sep; 53(9):1869-1880. PubMed ID: 32786331 [TBL] [Abstract][Full Text] [Related]
2. The Nano-Bio Interactions of Nanomedicines: Understanding the Biochemical Driving Forces and Redox Reactions. Wang Y; Cai R; Chen C Acc Chem Res; 2019 Jun; 52(6):1507-1518. PubMed ID: 31149804 [TBL] [Abstract][Full Text] [Related]
4. Nanomedicines for renal disease: current status and future applications. Kamaly N; He JC; Ausiello DA; Farokhzad OC Nat Rev Nephrol; 2016 Dec; 12(12):738-753. PubMed ID: 27795549 [TBL] [Abstract][Full Text] [Related]
5. Nanomedicines for kidney diseases. Williams RM; Jaimes EA; Heller DA Kidney Int; 2016 Oct; 90(4):740-5. PubMed ID: 27292222 [TBL] [Abstract][Full Text] [Related]
6. Physiological principles underlying the kidney targeting of renal nanomedicines. Huang Y; Ning X; Ahrari S; Cai Q; Rajora N; Saxena R; Yu M; Zheng J Nat Rev Nephrol; 2024 Jun; 20(6):354-370. PubMed ID: 38409369 [TBL] [Abstract][Full Text] [Related]
7. Dose Dependencies and Biocompatibility of Renal Clearable Gold Nanoparticles: From Mice to Non-human Primates. Xu J; Yu M; Peng C; Carter P; Tian J; Ning X; Zhou Q; Tu Q; Zhang G; Dao A; Jiang X; Kapur P; Hsieh JT; Zhao X; Liu P; Zheng J Angew Chem Int Ed Engl; 2018 Jan; 57(1):266-271. PubMed ID: 29160029 [TBL] [Abstract][Full Text] [Related]
8. Inorganic nanomedicines and their labeling for biological imaging. Kim KM; Kang JH; Vinu A; Choy JH; Oh JM Curr Top Med Chem; 2013; 13(4):488-503. PubMed ID: 23432011 [TBL] [Abstract][Full Text] [Related]
9. Renal clearable magnetic nanoparticles for magnetic resonance imaging and guided therapy. Zhang Q; Yin R; Guan G; Liu H; Song G Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(1):e1929. PubMed ID: 37752407 [TBL] [Abstract][Full Text] [Related]
11. Inorganic nanomaterials with rapid clearance for biomedical applications. Wang X; Zhong X; Li J; Liu Z; Cheng L Chem Soc Rev; 2021 Aug; 50(15):8669-8742. PubMed ID: 34156040 [TBL] [Abstract][Full Text] [Related]
12. Gold Nanoparticle Transport in the Injured Kidneys with Elevated Renal Function Biomarkers. Ning X; Zhong Y; Cai Q; Wang Y; Jia X; Hsieh JT; Zheng J; Yu M Adv Mater; 2024 Sep; 36(36):e2402479. PubMed ID: 39073056 [TBL] [Abstract][Full Text] [Related]
13. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators. Yang Y; Zhang M; Song H; Yu C Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182 [TBL] [Abstract][Full Text] [Related]
15. Engineering plasmonic gold nanostructures and metamaterials for biosensing and nanomedicine. Jin Y Adv Mater; 2012 Oct; 24(38):5153-65. PubMed ID: 22760939 [TBL] [Abstract][Full Text] [Related]
16. Mechanistic Insights into the Biological Effects of Engineered Nanomaterials: A Focus on Gold Nanoparticles. Nguyen NHA; Falagan-Lotsch P Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835521 [TBL] [Abstract][Full Text] [Related]
17. Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications. Ni D; Jiang D; Ehlerding EB; Huang P; Cai W Acc Chem Res; 2018 Mar; 51(3):778-788. PubMed ID: 29489335 [TBL] [Abstract][Full Text] [Related]
19. Redox-responsive theranostic nanoplatforms based on inorganic nanomaterials. Han L; Zhang XY; Wang YL; Li X; Yang XH; Huang M; Hu K; Li LH; Wei Y J Control Release; 2017 Aug; 259():40-52. PubMed ID: 28288893 [TBL] [Abstract][Full Text] [Related]
20. The Present and the Future of Degradable Dendrimers and Derivatives in Theranostics. Leiro V; Garcia JP; Tomás H; Pêgo AP Bioconjug Chem; 2015 Jul; 26(7):1182-97. PubMed ID: 25826129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]